Recent advances in medical therapy for metastatic urothelial cancer

Cytotoxic chemotherapy has been the mainstay of medical therapy for metastatic urothelial cancer. Currently, the gemcitabine/cisplatin regimen is widely used worldwide as the standard first-line medical treatment. Very recently, in 2017, pembrolizumab, a highly selective, humanized monoclonal IgG4κ...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuasa, Takeshi, Urakami, Shinji, Yonese, Junji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097083/
https://www.ncbi.nlm.nih.gov/pubmed/29556919
http://dx.doi.org/10.1007/s10147-018-1260-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097083/
https://www.ncbi.nlm.nih.gov/pubmed/29556919
http://dx.doi.org/10.1007/s10147-018-1260-0

Ejemplares similares